Company news
Xtalpi Holdings Limited (HKEX:2228) news
Every Xtalpi Holdings Limited press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program
September 22, 2026
XtalPi Holdings Limited to Announce 2026 Interim Results on August 19, 2026
August 11, 2026
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
June 10, 2026
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
May 29, 2026
XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
May 3, 2026
XtalPi Holdings Announces Full Year 2025 Annual Results
March 25, 2026
XtalPi Holdings Limited to Announce 2025 Annual Results on March 25, 2026
March 13, 2026
XtalPi's AI + Robotics Platform Powers First Clinical Milestone for ReviR's Rare Neurological Drug RTX-117
March 2, 2026
Leading Automation Capabilities of XtalPi Recognized by Global Chemical Giant - Successful Launch of Advanced Automated Workstation at BASF
February 9, 2026
XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision
January 29, 2026
XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development
November 5, 2025
XtalPi AI Drug Discovery Collaboration Reaches Milestone as PharmaEngine's Novel PRMT5 Inhibitor PEP08 Receives Clinical Trial Approvals
September 9, 2025
XtalPi Holdings Announces 2025 Interim Results
August 27, 2025
XtalPi Signs MOU with Dong-A ST for Joint Research and Development of Immunology and Inflammation Therapies
August 19, 2025
XtalPi Holdings Limited to Announce 2025 Interim Results on August 27, 2025
August 18, 2025
XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration
August 6, 2025
XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations
June 29, 2025
XtalPi Announces Strategic Collaboration with Harvard Professor Gregory Verdine's DoveTree LLC to Advance Novel Therapeutics Using AI+Robotics Drug Discovery Platform
June 22, 2025
XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration
June 13, 2025
XtalPi and Kula Bio Forge Multi-Million USD Collaborative R&D Agreement to Advance AI-Driven Microbial Fertilizers in China and the Middle East
March 28, 2025